Abstract:Background: Although Escherichia coli has been widely used for the expression of exogenous proteins, the secretory expression in this system is still a big obstacle. As one of the most important secretion pathways, hemolysin A (HlyA) system of E. coli can transport substrates directly from the cytoplasm to extracellular medium without the formation of any periplasmic intermediate, making it an ideal candidate for the development of the secretory production platform for exogenous proteins. Results: In this work, we developed a novel production platform, THHly, based on the HlyA secretion system, and explored its applications in the efficient preparation and quick detection of tag peptides and anti-microbial peptides. In this novel platform the signal sequence of HlyA is fused to the C-terminal of target peptide, with Tobacco Etch Virus (TEV) protease cleavage site and 6*His tag between them. Five tag peptides displayed good secretory properties in E. coli BL21 (DE3), among which T7 tag and S tag were obtained by two rounds of purification steps and TEV cleavage, and maintained their intrinsic immunogenicity. Furthermore, Cecropin A and Melittin, two different types of widely explored anti-microbial peptides, were produced likewise and verified to possess anti-microbial/anti-tumor bioactivities. No significant bacterial growth inhibition was observed during the fusion protein expression, indicating that the fusion form not only mediated the secretion but also decreased the toxicity of anti-microbial peptides (AMPs) to the host bacteria. To the best of our knowledge, this is the first report to achieve the secretory expression of these two AMPs in E. coli with considerable potential for manufacturing and industrialization purposes. Conclusions: The results demonstrate that the HlyA based novel production platform of E. coli allowed the efficient secretory production and purification of peptides, thus suggesting a promising strategy for the industrialized production of peptide pharmaceuticals or reagents.

Design and Unique Expression of a Novel Antibacterial Fusion Protein Cecropin B-Human Lysozyme to Be Toxic to Prokaryotic Host Cells

High-level expression of soluble subunit <i>b</i> of F<sub>1</sub>F<sub>0</sub> ATP synthase in <i>Escherichia coli</i> cell-free system

High-level expression of soluble subunit b of F 1 F 0 ATP synthase in Escherichia coli cell-free system

Fusion expression of cecropin B-like antibacterial peptide in Pichia GS115 and its antibacterial mechanism

Bactericidal Effect of Cecropin A Fused Endolysin on Drug-Resistant Gram-Negative Pathogens

Unveiling the mechanism of bactericidal activity of a cecropin A-fused endolysin LNT113

Design, expression, and characterization of a novel cecropin A-derived peptide with high antibacterial activity

A hemolysin secretion pathway-based novel secretory expression platform for efficient manufacturing of tag peptides and anti-microbial peptides in Escherichia coli

Expressing Antimicrobial Peptide Cathelicidin-Bf in Bacillus Subtilis Using Sumo Technology

High-level Expression,Purification and Activity of the Plectasin

Soluble fusion expression and characterization of bioactive human beta-defensin 26 and 27

High-level Production of Bioactive Human Beta-Defensin-4 in Escherichia Coli by Soluble Fusion Expression

Design and high-level expression of a hybrid antimicrobial peptide LF15-CA8 in Escherichia coli

Prokaryotic Expression and Functional Verification of Antimicrobial Peptide LRGG

High-level Expression of Soluble Human Β-Defensin-2 in Escherichia Coli

Enhanced Expression and Primary Purification of Soluble HBD3 Fusion Protein in Escherichia coli

Expression of Hybrid Peptide EF-1 in Pichia pastoris, Its Purification, and Antimicrobial Characterization

High-level SUMO-mediated Fusion Expression of ABP-dHC-cecropin A from Multiple Joined Genes in Escherichia Coli.

Expression of the hybrid antimicrobial peptide lactoferrin–lysozyme in Pichia pastoris

Design and Production of a Chimeric Enzyme with Efficient Antibacterial Properties on Staphylococcus aureus

Heterologous expression of enterocin A, a bacteriocin from Enterococcus faecium, fused to a cellulose-binding domain in Escherichia coli results in a functional protein with inhibitory activity against Listeria